Name
Agios Pharmaceuticals
Company Description
Agios develops and delivers therapies for rare disease patients. The company markets a PK activator for PK deficiency in the U.S. and is advancing a pipeline of investigational medicines for thalassemia, sickle cell disease, and MDS-associated anemia.

Website
https://www.agios.com/
Address
38 Sidney Street
Cambridge, 02139
United States